Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
483,928
-
Share change
-
-499,997
-
Total reported value
-
$6,343,634
-
Price per share
-
$13.11
-
Number of holders
-
13
-
Value change
-
-$3,188,708
-
Number of buys
-
11
-
Number of sells
-
3
Institutional Holders of Nuvectis Pharma, Inc. - COM (NVCT) as of Q1 2023
As of 31 Mar 2023 Nuvectis Pharma, Inc. - COM (NVCT) had 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 483,928 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BALDWIN BROTHERS LLC/MA, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, EDMOND DE ROTHSCHILD HOLDING S.A., BlackRock Inc., STATE STREET CORP, Man Group plc, JANE STREET GROUP, LLC, and MORGAN STANLEY.
This table shows 13 institutional shareholders of the security as of 31 Mar 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.